Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon F Keele

Showing results (221-230 of 227) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 227 results.
Science Translational Medicine|April 29, 2026
Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaquesHelen L Wu, Gabriela M Webb, Sebastian P Fuchs, et al.
Cell Reports|January 5, 2022
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeysAmarendra Pegu, Ling Xu, Megan E DeMouth, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2008
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionBrandon F Keele, Elena E Giorgi, Jesus F Salazar-Gonzalez, et al.
Plos Pathogens|October 8, 2011
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsS Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Nature Medicine|May 31, 2016
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 23

Showing results (221-230 of 227) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 227 results.
Science Translational Medicine|April 29, 2026
Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaquesHelen L Wu, Gabriela M Webb, Sebastian P Fuchs, et al.
Cell Reports|January 5, 2022
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeysAmarendra Pegu, Ling Xu, Megan E DeMouth, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2008
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionBrandon F Keele, Elena E Giorgi, Jesus F Salazar-Gonzalez, et al.
Plos Pathogens|October 8, 2011
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsS Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Nature Medicine|May 31, 2016
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Pageof 23